Skip to Main Content
Page banner

CE marked, automated, multianaltical, quick, antigen test

ArcDia is the market leader in Finland for respiratory disease diagnostics with its automated, rapid, multianalytical test system. The capacity of one analyser is 300 COVID-19 tests per day or 100 multianalytical Respi+ tests (including COVID-19) per day.

Have you validated this method, if so, how and what were the results of the validation?

yes both the single analyte SARS-CoV-2 test and the multianalyte test Respi+ are CE marked.

Is the method already deployed in a UK hospital or clinical setting?


Where is the kit manufactured?

In. Finland

What is the turn around time (sample-to-result) for this method?

20 minutes to 2 hours, depending on the test.

How will your solution communicate directly with the Laboratory Information Management System (LIMS)?

yes, we are connected to LIMS and we provide our own cloud-based platform for visualising data as time series and on a map. Data is collected in real-time so our map shows the real-time epidemiological situation in the covered area.

How quickly could this be deployed and what are the dependencies?

We are shipping analysers and tests globally as we speak.

What is the likely production volume?

We are producing millions of tests.

What are the risks and barriers to using this at scale?

The bottle neck is typically patient logistics and safe sample taking.

Who are you already partnering with on this?

Private and public customers globally.

edited on Jul 28, 2020 by Vesa Kemppainen
You will need to login to post a comment
No comments yet, be the first to post one!